Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristell Desseaux

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
BMC Medical Research Methodology|August 8, 2012
What inference for two-stage phase II trials?Raphaël Porcher, Kristell Desseaux
Plos One|March 29, 2017
Correlation between clinical severity and different non-invasive measurements of carbon monoxide concentration: A population studyThomas Hullin, Jerome Aboab, Kristell Desseaux, et al.
Autoimmunity Reviews|November 15, 2013
Are anti-proteinase-3 ANCA a useful marker of granulomatosis with polyangiitis (Wegener's) relapses? Results of a retrospective study on 126 patientsLan-Huong Thai, Pierre Charles, Matthieu Resche-Rigon, et al.
Human Pathology|August 24, 2007
Clinical and histological characteristics of renal AA amyloidosis: a retrospective study of 68 cases with a special interest to amyloid-associated inflammatory responseJérôme Verine, Nathalie Mourad, Kristell Desseaux, et al.
Journal of the International AIDS Society|November 15, 2014
Efficacy and safety of rilpivirine-based regimens in treatment-experienced HIV-1 infected patients: a prospective cohort studySandrine Gazaignes, Matthieu Resche-Rigon, Chloe Yang, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|October 7, 2014
Natural history of allergic sensitization in infants with early-onset atopic dermatitis: results from ORCA StudyJocelyne Just, Emmanuelle Deslandes-Boutmy, Flore Amat, et al.
Haematologica|November 2, 2018
A phase II study of the efficacy and safety of an intensified schedule of azacytidine in intermediate-2 and high-risk patients with myelodysplastic syndromes: a study by the Groupe Francophone des Myelodysplasies (GFM)Lionel Ades, Agnès Guerci-Bresler, Pascale Cony-Makhoul, et al.
Antiviral Therapy|November 14, 2015
Efficacy and safety of a switch to rilpivirine-based regimens in treatment-experienced HIV-1-infected patients: a cohort studySandrine Gazaignes, Matthieu Resche-Rigon, Caroline Gatey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 2, 2011
The complex relationship between human herpesvirus 6 and acute graft-versus-host diseaseClaire Pichereau, Kristell Desseaux, Anne Janin, et al.
Rheumatology (Oxford, England)|July 6, 2024
Impact of conventional and biological disease-modifying anti-rheumatic drugs on arterial lesions in Takayasu arteritisDiego Bletry, Louis Meyblum, Kristell Desseaux, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
BMC Medical Research Methodology|August 8, 2012
What inference for two-stage phase II trials?Raphaël Porcher, Kristell Desseaux
Plos One|March 29, 2017
Correlation between clinical severity and different non-invasive measurements of carbon monoxide concentration: A population studyThomas Hullin, Jerome Aboab, Kristell Desseaux, et al.
Autoimmunity Reviews|November 15, 2013
Are anti-proteinase-3 ANCA a useful marker of granulomatosis with polyangiitis (Wegener's) relapses? Results of a retrospective study on 126 patientsLan-Huong Thai, Pierre Charles, Matthieu Resche-Rigon, et al.
Human Pathology|August 24, 2007
Clinical and histological characteristics of renal AA amyloidosis: a retrospective study of 68 cases with a special interest to amyloid-associated inflammatory responseJérôme Verine, Nathalie Mourad, Kristell Desseaux, et al.
Journal of the International AIDS Society|November 15, 2014
Efficacy and safety of rilpivirine-based regimens in treatment-experienced HIV-1 infected patients: a prospective cohort studySandrine Gazaignes, Matthieu Resche-Rigon, Chloe Yang, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|October 7, 2014
Natural history of allergic sensitization in infants with early-onset atopic dermatitis: results from ORCA StudyJocelyne Just, Emmanuelle Deslandes-Boutmy, Flore Amat, et al.
Haematologica|November 2, 2018
A phase II study of the efficacy and safety of an intensified schedule of azacytidine in intermediate-2 and high-risk patients with myelodysplastic syndromes: a study by the Groupe Francophone des Myelodysplasies (GFM)Lionel Ades, Agnès Guerci-Bresler, Pascale Cony-Makhoul, et al.
Antiviral Therapy|November 14, 2015
Efficacy and safety of a switch to rilpivirine-based regimens in treatment-experienced HIV-1-infected patients: a cohort studySandrine Gazaignes, Matthieu Resche-Rigon, Caroline Gatey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 2, 2011
The complex relationship between human herpesvirus 6 and acute graft-versus-host diseaseClaire Pichereau, Kristell Desseaux, Anne Janin, et al.
Rheumatology (Oxford, England)|July 6, 2024
Impact of conventional and biological disease-modifying anti-rheumatic drugs on arterial lesions in Takayasu arteritisDiego Bletry, Louis Meyblum, Kristell Desseaux, et al.
Pageof 3